AI News NQ Analysis

[Co-Yea Biotech] February 2026 Monthly Revenue: NT$ 0.55 Billion (YoY +0.1%)

NQ Score 48/100
N1 Content Completeness 3

AI Summary (NQ-processed)

Co-Yea Biotech (1786), a biotechnology and medical enterprise, announced its February 2026 revenue report. The company's revenue for the month was NT$ 0.55 billion (NT$ 55,099 thousand), marking a slight year-on-year increase of 0.1%, maintaining relatively stable operational performance.

AI analysis data is not yet available.

Frequently Asked Questions

Q: What was Co-Yea Biotech's revenue for February 2026?
A: Co-Yea Biotech's revenue for February 2026 was NT$ 55,099 thousand, which is equivalent to NT$ 0.55 billion.
Q: How did Co-Yea Biotech's February 2026 revenue compare to the same month last year?
A: Co-Yea Biotech's revenue in February 2026 showed a year-over-year increase of +0.1% compared to the same month in the previous year.
Q: What is the company code for Co-Yea Biotech?
A: The company code for Co-Yea Biotech is 1786.
Q: In which industry does Co-Yea Biotech operate?
A: Co-Yea Biotech operates within the Biotechnology and Medical Industry.
Q: What was the exact revenue figure in thousands for Co-Yea Biotech in February 2026?
A: The exact revenue figure for Co-Yea Biotech in February 2026 was NT$ 55,099 thousand.